Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
23 hedge funds and large institutions have $42.1M invested in Roivant Sciences Ltd. Warrant in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 7 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $48.9M → $42.1M (-$6.79M)
18% less funds holding
Funds holding: 28 → 23 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOA
Sea Otter Advisors
Miami,
Florida
|
+$709K |
| 2 |
TSC
Two Seas Capital
Rye,
New York
|
+$601K |
| 3 |
Walleye Capital
New York
|
+$557K |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
+$509K |
| 5 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$391K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$890K |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$834K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$625K |
| 4 |
PVI
Pura Vida Investments
New York
|
-$387K |
| 5 |
CAC
Cowen and Company
New York
|
-$120K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PVI
26
Pura Vida Investments
New York
| – | -$387K | -199,648 | Closed |
|
|
CAC
27
Cowen and Company
New York
| – | -$120K | -62,100 | Closed |
|
|
DC
28
Diametric Capital
Boston,
Massachusetts
| – | -$115K | -59,533 | Closed |
|
|
PCM
29
Prelude Capital Management
New York
| – | -$43.9K | -22,606 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | -$2.22K | -1,145 | Closed |
|
ROIVW Hedge Fund Activity: Q1 2023 in Review
23 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q1 2023, worth a combined $42.1M — down 14% from $48.9M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ROIVW and 2 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 9 added.
The largest buyer was Sea Otter Advisors, opening a new position worth an estimated $709K. The largest seller was Ionic Capital Management, exiting entirely with an estimated $890K sold.
- 23 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q1 2023, down from 28 in Q4 2022.
- Funds reported $42.1M of Roivant Sciences Ltd. Warrant stock for Q1 2023, down 14% quarter-over-quarter.
- 2 funds opened new Roivant Sciences Ltd. Warrant positions in Q1 2023 and 7 closed out, a net change of -5 holders.
- The largest Roivant Sciences Ltd. Warrant buyer in Q1 2023 was Sea Otter Advisors, an estimated $709K added.
- The largest Roivant Sciences Ltd. Warrant seller in Q1 2023 was Ionic Capital Management, an estimated $890K sold.
Based on aggregated 13F filings for Q1 2023.